Global Next Generation Sequencing NGS Services Market Overview And Scope:
Global Next Generation Sequencing NGS Services Market Size was estimated at USD 4268.87 million in 2022 and is projected to reach USD 10163.01 million by 2028, exhibiting a CAGR of 15.55% during the forecast period.
The Global Next Generation Sequencing NGS Services Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Next Generation Sequencing NGS Services utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, Novogene, Genotypic Technology, Dna Link
Global Next Generation Sequencing NGS Services Market Segmentation
By Type, Next Generation Sequencing NGS Services market has been segmented into:Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Next-Generation Sequencing (NGS)
By Application, Next Generation Sequencing NGS Services market has been segmented into:
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Next Generation Sequencing NGS Services market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Next Generation Sequencing NGS Services market.
Top Key Players Covered in Next Generation Sequencing NGS Services market are:
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Objective to buy this Report:
1. Next Generation Sequencing NGS Services analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Next Generation Sequencing NGS Services market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Next Generation Sequencing NGS Services Market by Type
5.1 Next Generation Sequencing NGS Services Market Overview Snapshot and Growth Engine
5.2 Next Generation Sequencing NGS Services Market Overview
5.3 Targeted Sequencing
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Targeted Sequencing: Geographic Segmentation
5.4 Whole Exome Sequencing
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Whole Exome Sequencing: Geographic Segmentation
5.5 Whole Genome Sequencing
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Whole Genome Sequencing: Geographic Segmentation
5.6 Next-Generation Sequencing (NGS)
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Next-Generation Sequencing (NGS): Geographic Segmentation
Chapter 6: Next Generation Sequencing NGS Services Market by Application
6.1 Next Generation Sequencing NGS Services Market Overview Snapshot and Growth Engine
6.2 Next Generation Sequencing NGS Services Market Overview
6.3 Hospitals and Clinics
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals and Clinics: Geographic Segmentation
6.4 Biopharma Companies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Biopharma Companies: Geographic Segmentation
6.5 Academic and Research Organizations
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Academic and Research Organizations: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Next Generation Sequencing NGS Services Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Next Generation Sequencing NGS Services Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Next Generation Sequencing NGS Services Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 EUROFINS SCIENTIFIC
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 NATERA
7.4 BGI
7.5 ILLUMINA
7.6 ROCHE
7.7 LABCORP
7.8 BERRY GENOMICS
7.9 BROOKS LIFE SCIENCES
7.10 MACROGEN
7.11 PERSONALIS
7.12 NOVOGENE
7.13 GENOTYPIC TECHNOLOGY
7.14 DNA LINK
Chapter 8: Global Next Generation Sequencing NGS Services Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Targeted Sequencing
8.2.2 Whole Exome Sequencing
8.2.3 Whole Genome Sequencing
8.2.4 Next-Generation Sequencing (NGS)
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals and Clinics
8.3.2 Biopharma Companies
8.3.3 Academic and Research Organizations
8.3.4 Others
Chapter 9: North America Next Generation Sequencing NGS Services Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Targeted Sequencing
9.4.2 Whole Exome Sequencing
9.4.3 Whole Genome Sequencing
9.4.4 Next-Generation Sequencing (NGS)
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals and Clinics
9.5.2 Biopharma Companies
9.5.3 Academic and Research Organizations
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Next Generation Sequencing NGS Services Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Targeted Sequencing
10.4.2 Whole Exome Sequencing
10.4.3 Whole Genome Sequencing
10.4.4 Next-Generation Sequencing (NGS)
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals and Clinics
10.5.2 Biopharma Companies
10.5.3 Academic and Research Organizations
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Next Generation Sequencing NGS Services Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Targeted Sequencing
11.4.2 Whole Exome Sequencing
11.4.3 Whole Genome Sequencing
11.4.4 Next-Generation Sequencing (NGS)
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals and Clinics
11.5.2 Biopharma Companies
11.5.3 Academic and Research Organizations
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Next Generation Sequencing NGS Services Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Targeted Sequencing
12.4.2 Whole Exome Sequencing
12.4.3 Whole Genome Sequencing
12.4.4 Next-Generation Sequencing (NGS)
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals and Clinics
12.5.2 Biopharma Companies
12.5.3 Academic and Research Organizations
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Next Generation Sequencing NGS Services Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Targeted Sequencing
13.4.2 Whole Exome Sequencing
13.4.3 Whole Genome Sequencing
13.4.4 Next-Generation Sequencing (NGS)
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals and Clinics
13.5.2 Biopharma Companies
13.5.3 Academic and Research Organizations
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Next Generation Sequencing NGS Services Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Targeted Sequencing
14.4.2 Whole Exome Sequencing
14.4.3 Whole Genome Sequencing
14.4.4 Next-Generation Sequencing (NGS)
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospitals and Clinics
14.5.2 Biopharma Companies
14.5.3 Academic and Research Organizations
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Next Generation Sequencing NGS Services Scope:
|
Report Data
|
Next Generation Sequencing NGS Services Market
|
|
Next Generation Sequencing NGS Services Market Size in 2025
|
USD XX million
|
|
Next Generation Sequencing NGS Services CAGR 2025 - 2032
|
XX%
|
|
Next Generation Sequencing NGS Services Base Year
|
2024
|
|
Next Generation Sequencing NGS Services Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Personalis, Novogene, Genotypic Technology, Dna Link.
|
|
Key Segments
|
By Type
Targeted Sequencing
Whole Exome Sequencing
Whole Genome Sequencing
Next-Generation Sequencing (NGS)
By Applications
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
|
